Latest Quarter
2026-04-07
Concord Healthcare Grp Co Ltd (2453.HK)
Revenue
$201M
Net Income
-$177M
Operating Margin
-59.9%
Free Cash Flow
-$500M
Debt / Assets
65.0%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2026-04-07 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | 200,903,000 | 254,697,634 | 200,903,000 | 100,451,500 |
| Cost of Revenue | 200,520,000 | 223,657,285 | 200,520,000 | 100,260,000 |
| Gross Profit | 383,000 | 31,040,348 | 383,000 | 191,500 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 107,125,000 | 125,180,113 | 107,125,000 | 53,562,500 |
| Operating Expenses | 120,743,000 | 139,491,299 | 120,743,000 | 60,371,500 |
| Operating Income | -120,360,000 | -108,450,950 | -120,360,000 | -60,180,000 |
| Interest Expense | 0 | 56,246,681 | 66,328,998 | 0 |
| Income Before Tax | -201,992,000 | -106,226,688 | -201,992,000 | -100,996,000 |
| Income Tax Expense | 1,971,000 | -2,216,394 | 1,971,000 | 985,500 |
| Net Income | -176,598,000 | -78,670,229 | -176,598,000 | -88,299,000 |
| Per Share | ||||
| EPS | -0.24 | -0.10 | -0.24 | -0.12 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | 448,018,708 | 388,305,000 | 538,650,000 |
| Cost of Revenue | 416,895,610 | 455,553,000 | 603,739,000 |
| Gross Profit | 31,123,097 | -67,248,000 | -65,089,000 |
| Operating Expenses | |||
| R&D Expenses | 0 | 0 | 0 |
| SG&A Expenses | 235,843,924 | 259,357,000 | 252,965,000 |
| Operating Expenses | 263,286,801 | 330,299,000 | 288,577,000 |
| Operating Income | -232,163,702 | -371,207,000 | -353,666,000 |
| Interest Expense | 120,332,905 | 109,267,000 | 108,006,000 |
| Income Before Tax | -301,997,312 | -485,849,000 | -432,592,000 |
| Income Tax Expense | -4,115,652 | -1,031,000 | -6,198,000 |
| Net Income | -249,961,829 | -443,223,000 | -373,090,000 |
| Per Share | |||
| EPS | -0.33 | -0.62 | -0.52 |
| EPS Diluted | 0.00 | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Assets | |||
| Cash and Cash Equivalents | 319,007,420 | 204,544,000 | 40,577,000 |
| Short Term Investments | 0 | 132,575,000 | 8,656,000 |
| Net Receivables | 48,992,951 | 193,051,000 | 75,984,000 |
| Inventory | 16,853,206 | 33,441,000 | 40,347,000 |
| Total Current Assets | 669,954,499 | 713,620,000 | 359,801,000 |
| Property Plant Equipment | 3,892,288,502 | 3,930,349,000 | 3,448,393,000 |
| Goodwill and Intangibles | 0 | 826,372,000 | 851,667,000 |
| Total Assets | 5,789,882,992 | 5,906,562,000 | 5,236,396,000 |
| Liabilities | |||
| Account Payables | 82,734,380 | 112,146,000 | 127,069,000 |
| Short Term Debt | 631,931,239 | 402,617,000 | 548,044,000 |
| Total Current Liabilities | 1,246,236,942 | 1,135,864,000 | 1,204,517,000 |
| Long Term Debt | 2,458,850,505 | 2,807,302,000 | 2,094,604,000 |
| Total Liabilities | 3,763,209,302 | 4,005,752,000 | 3,367,211,000 |
| Shareholders Equity | |||
| Retained Earnings | 0 | -3,746,678,000 | -3,303,455,000 |
| Total Shareholders Equity | 1,831,033,024 | 1,647,897,000 | 1,599,089,000 |
| Balance Sheet (Annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Assets | |||
| Cash and Cash Equivalents | 319,007,420 | 204,544,000 | 40,577,000 |
| Short Term Investments | 0 | 132,575,000 | 8,656,000 |
| Net Receivables | 48,992,951 | 193,051,000 | 75,984,000 |
| Inventory | 16,853,206 | 33,441,000 | 40,347,000 |
| Total Current Assets | 669,954,499 | 713,620,000 | 359,801,000 |
| Property Plant Equipment | 3,892,288,502 | 3,930,349,000 | 3,448,393,000 |
| Goodwill and Intangibles | 0 | 826,372,000 | 851,667,000 |
| Total Assets | 5,789,882,992 | 5,906,562,000 | 5,236,396,000 |
| Liabilities | |||
| Account Payables | 82,734,380 | 112,146,000 | 127,069,000 |
| Short Term Debt | 631,931,239 | 402,617,000 | 548,044,000 |
| Total Current Liabilities | 1,246,236,942 | 1,135,864,000 | 1,204,517,000 |
| Long Term Debt | 2,458,850,505 | 2,807,302,000 | 2,094,604,000 |
| Total Liabilities | 3,763,209,302 | 4,005,752,000 | 3,367,211,000 |
| Shareholders Equity | |||
| Retained Earnings | 0 | -3,746,678,000 | -3,303,455,000 |
| Total Shareholders Equity | 1,831,033,024 | 1,647,897,000 | 1,599,089,000 |
| Cash Flow Statement (Quarterly) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -443,223,000 | -432,592,000 |
| Depreciation & Amortization | 114,062,000 | 152,007,000 |
| Stock Based Compensation | 0 | 0 |
| Change in Working Capital | 70,590,000 | 403,706,000 |
| Operating Cash Flow | -185,964,000 | 201,853,000 |
| Investing Activities | ||
| Capital Expenditure | -314,156,000 | -183,748,000 |
| Investments | 0 | -177,931,000 |
| Investing Cash Flow | -668,087,000 | -182,341,000 |
| Financing Activities | ||
| Debt Repayment | 701,456,000 | -19,709,000 |
| Common Stock Issued/Repurchased | 517,886,000 | 300,000,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 1,018,018,000 | -105,431,000 |
| Summary | ||
| Free Cash Flow | -500,120,000 | 18,105,000 |
| Net Change in Cash | 163,967,000 | -85,919,000 |
| Cash Flow Statement (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -443,223,000 | -432,592,000 |
| Depreciation & Amortization | 114,062,000 | 152,007,000 |
| Stock Based Compensation | 0 | 0 |
| Change in Working Capital | 70,590,000 | 403,706,000 |
| Operating Cash Flow | -185,964,000 | 201,853,000 |
| Investing Activities | ||
| Capital Expenditure | -314,156,000 | -183,748,000 |
| Investments | 0 | -177,931,000 |
| Investing Cash Flow | -668,087,000 | -182,341,000 |
| Financing Activities | ||
| Debt Repayment | 701,456,000 | -19,709,000 |
| Common Stock Issued/Repurchased | 517,886,000 | 300,000,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 1,018,018,000 | -105,431,000 |
| Summary | ||
| Free Cash Flow | -500,120,000 | 18,105,000 |
| Net Change in Cash | 163,967,000 | -85,919,000 |